UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

The Lancet (British edition), 1993-05, Vol.341 (8855), p.1242-1243

1993

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3210-3218

2001

Volltextzugriff (PDF)

Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer

European journal of cancer (1990), 2021-09, Vol.154, p.11-20

2021

Volltextzugriff (PDF)

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

Journal of clinical oncology, 1995-08, Vol.13 (8), p.1880-1892

1995

Volltextzugriff (PDF)

Sustainability of Tobacco Treatment Programs in the Cancer Center Cessation Initiative

Journal of the National Comprehensive Cancer Network, 2021-11, Vol.19 (Suppl_1), p.S16-S20

_, _

2021

Volltextzugriff (PDF)

Data envelopment analysis to evaluate the efficiency of tobacco treatment programs in the NCI Moonshot Cancer Center Cessation Initiative

Implementation science communications, 2023-05, Vol.4 (1), p.50-13, Article 50

2023

Volltextzugriff (PDF)

Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2002-02, Vol.94 (4), p.291-297

2002

Volltextzugriff (PDF)

Abstract 3677: Incorporating societal determinants of health with implementation science to increase tobacco cessation patient and community responsiveness

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3677-3677

2022

Volltextzugriff (PDF)

Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes

The Lancet (British edition), 1990-06, Vol.335 (8701), p.1307-1309

1990

Volltextzugriff (PDF)

Abstract P3-06-28: Use of the MiCK drug-induced apoptosis assay improves clinical outcomes in recurrent breast cancer (BRCA)

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P3-P3-06-28

2012

Volltextzugriff (PDF)

Endometrial carcinoma in-vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic (MICK) apoptosis assay: Implications for endometrial cancer treatment

Gynecologic oncology, 2010-03, Vol.116 (3), p.595-595

2010

Volltextzugriff (PDF)

Chemosensitivity (CS) of patient (pt) breast cancer (BrCa) cells in vitro: Correlation with prior chemotherapy (CT) and implications for personalized treatment planning

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e11563-e11563

2009

Volltextzugriff (PDF)

Can we increase response rate (RR) and overall survival (OS) by individualizing chemotherapy in ovarian cancer (OC): The role of a new chemotherapy (CT) induced apoptosis assay

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5112-5112

2010

Volltextzugriff (PDF)

Pharmacokinetic (PK) and pharmacodynamic (PD) study of the effect of imatinib (Ima) on tumor (T) vascularity (V) and on gemcitabine (Ge) uptake (U) using non-invasive dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) and spectroscopy (MRS)—Study BUS228

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.12006-12006

2006

Volltextzugriff (PDF)

Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group Study

Investigational new drugs, 2002-11, Vol.20 (4), p.369-376

2002

Volltextzugriff (PDF)

Development of a model emergency oncology response system (EORS): The California oncology emergency master plan (COEMP)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.6142-6142

2006

Volltextzugriff (PDF)

Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy

Journal of clinical oncology, 2000-01, Vol.18 (2), p.255

2000

Volltextzugriff (PDF)

Multilesion coronary angioplasty: Clinical and angiographic follow-up

Journal of the American College of Cardiology, 1987-08, Vol.10 (2), p.246-252

1987

Volltextzugriff (PDF)

Heterogeneous monitoring for and management of bevacizumab (BE) toxicity (T): Develpment of standardized guidelines for monitoring (mon) and treatment (tre) of the BE toxicity syndrome (BETS)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8224-8224

2005

Volltextzugriff (PDF)

Re-evaluation of benefits of BRCA1/2 testing

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1962-1962

1999

Volltextzugriff (PDF)

Liposomal Blockade of the Reticuloendothelial System: Improved Tumor Imaging with Small Unilamellar Vesicles

Science (American Association for the Advancement of Science), 1983-04, Vol.220 (4596), p.502-505

1983

Volltextzugriff (PDF)

Increasing accrual (Ac) to clinical trials (CT) in community cancer clinics (CCC): A successful method using electronic medical records (EMR), virtual private network (VPN) and focused group activities (FGA)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.6088-6088

2005

Volltextzugriff (PDF)

Incidence of bevacizumab (BE) related toxicities: Association of hypertension (HTN) and proteinuria (PTN), a BE toxicity syndrome (BETS)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8062-8062

2005

Volltextzugriff (PDF)

Development and implementation of effective quality (Q) guidelines (G) in community (com) cancer centers (CC): The cancer quality program (CQP)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.6105-6105

2005

Volltextzugriff (PDF)

In-111-labeled liposomes: dosimetry and tumor depiction

Radiology, 1988-03, Vol.166 (3), p.761-765

1988

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(83)
Berichte
(2)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

Humans
(46)
Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Male
(31)
Female
(28)
Middle Aged
(28)
Oncology
(28)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Adult
(22)
Aged
(20)
Pharmacology. Drug Treatments
(15)
Antineoplastic Agents
(14)
Chemotherapy
(14)
Animals
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Drug Evaluation
(6)
Tumors
(6)
Adolescent
(5)
Breast Neoplasms - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

Sustainability of Tobacco Treatment Programs in the Cancer Center Cessation Initiative

Data envelopment analysis to evaluate the efficiency of tobacco treatment programs in the NCI Moonshot Cancer Center Cessation Initiative

Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer

Abstract 3677: Incorporating societal determinants of health with implementation science to increase tobacco cessation patient and community responsiveness

Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes

Abstract P3-06-28: Use of the MiCK drug-induced apoptosis assay improves clinical outcomes in recurrent breast cancer (BRCA)

Endometrial carcinoma in-vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic (MICK) apoptosis assay: Implications for endometrial cancer treatment

Chemosensitivity (CS) of patient (pt) breast cancer (BrCa) cells in vitro: Correlation with prior chemotherapy (CT) and implications for personalized treatment planning

Can we increase response rate (RR) and overall survival (OS) by individualizing chemotherapy in ovarian cancer (OC): The role of a new chemotherapy (CT) induced apoptosis assay

Pharmacokinetic (PK) and pharmacodynamic (PD) study of the effect of imatinib (Ima) on tumor (T) vascularity (V) and on gemcitabine (Ge) uptake (U) using non-invasive dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) and spectroscopy (MRS)—Study BUS228

Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group Study

Development of a model emergency oncology response system (EORS): The California oncology emergency master plan (COEMP)

Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy

Multilesion coronary angioplasty: Clinical and angiographic follow-up

Heterogeneous monitoring for and management of bevacizumab (BE) toxicity (T): Develpment of standardized guidelines for monitoring (mon) and treatment (tre) of the BE toxicity syndrome (BETS)

Re-evaluation of benefits of BRCA1/2 testing

Liposomal Blockade of the Reticuloendothelial System: Improved Tumor Imaging with Small Unilamellar Vesicles

Increasing accrual (Ac) to clinical trials (CT) in community cancer clinics (CCC): A successful method using electronic medical records (EMR), virtual private network (VPN) and focused group activities (FGA)

Incidence of bevacizumab (BE) related toxicities: Association of hypertension (HTN) and proteinuria (PTN), a BE toxicity syndrome (BETS)

Development and implementation of effective quality (Q) guidelines (G) in community (com) cancer centers (CC): The cancer quality program (CQP)

In-111-labeled liposomes: dosimetry and tumor depiction

Suchergebnisse filtern